Sunesis: Q4 Earnings Snapshot

CARDIFF, Calif. (AP) — CARDIFF, Calif. (AP) — Viracta Therapeutics, Inc. (VIRX) on Monday reported a loss of $10.3 million in its fourth quarter.

On a per-share basis, the Cardiff, California-based company said it had a loss of 27 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.

For the year, the company reported a loss of $49.2 million, or $1.30 per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VIRX at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up